Anika Therapeutics Inc. · NASDAQ:ANIK
Trigran Investments, Inc.'s stake in Anika Therapeutics Inc. fell to 1.20% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 8, 2026
Trigran Investments, Inc.'s stake in Anika Therapeutics Inc. fell to 1.20%, 168,400 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 1.20%
- Shares
- 168,400
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trigran Investments, Inc. | 1.20% | 168,400 |
| Douglas T. Granat | 1.20% | 168,400 |
| Lawrence A. Oberman | 1.20% | 168,400 |
| Steven G. Simon | 1.20% | 168,400 |
| Bradley F. Simon | 1.20% | 168,400 |
| Steven R. Monieson | 1.20% | 168,400 |
Source
Related
- Anika Therapeutics Inc.
- Trigran Investments, Inc.
- Anika Therapeutics Inc. shareholders
- Schedule 13G/A · Trigran Investments, Inc. · Nov 7, 2025
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026